CD5 and B-cell chronic lymphocytic leukemia: CXCR4 and CD5 cell-surface molecules can be used to distinguish CLL cells that have recently exited immune niches (CXCR4dimCD5bright cells) and harbor the fingerprint of the microenvironmental interactions [2, 15, 24, 28–33].